M4344

· EMD Serono Research & Development Institute, Inc.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for M4344, covering 2023-03-16 to 2023-03-16. Get the full timeline:

Most recent: Clinical Trial Update: First in Human Study of M4344 in Participants With Advanced Solid Tumors [Phase 1]